High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH)
- PMID: 12484570
- DOI: 10.1093/jnen/61.12.1078
High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH)
Abstract
Due to recent biological and technical advances, the list of potentially useful candidate genes is rapidly expanding in the study of brain tumors. However, traditional methods of screening individual genes in individual samples are slow and tedious, often with consumption of precious resources after only a few experiments. This study evaluates the feasibility of high-throughput molecular analysis using fluorescence in situ hybridization (FISH) on glioma tissue microarrays (TMA). A single microarray paraffin block was constructed using 65 WHO grade III and IV astrocytomas, sampled in duplicate with 0.6-mm-diameter punch cores. FISH was used to detect common alterations, such as EGFR amplification, chromosome 7, 9, and 10 aneusomies and deletions of 1p, 19q, PTEN, DMBT1, and p16. Of 585 hybridization sets, 508 (87%) yielded interpretable data, with hybridization failure in 33 (5.5%) and dislodged tissue in 44 sets (7.5%), respectively. Glioblastomas harbored significantly more alterations than anaplastic astrocytomas, with the overall frequencies of alterations similar to those reported using other techniques. The overall concordance rate between paired tumor core samples was 93%. We conclude that TMA-FISH is an efficient and reliable method for detecting molecular alterations in high-grade astrocytomas.
Similar articles
-
Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features.J Neuropathol Exp Neurol. 2003 Nov;62(11):1118-28. doi: 10.1093/jnen/62.11.1118. J Neuropathol Exp Neurol. 2003. PMID: 14656070
-
PTEN protein expression correlates with PTEN gene molecular changes but not with VEGF expression in astrocytomas.Diagn Mol Pathol. 2003 Sep;12(3):160-5. doi: 10.1097/00019606-200309000-00007. Diagn Mol Pathol. 2003. PMID: 12960698
-
PTEN, DMBT1, and p16 alterations in diffusely infiltrating astrocytomas.Int J Oncol. 2002 Sep;21(3):667-74. Int J Oncol. 2002. PMID: 12168116
-
Molecular pathogenesis of malignant gliomas.Curr Opin Oncol. 1999 May;11(3):162-7. doi: 10.1097/00001622-199905000-00004. Curr Opin Oncol. 1999. PMID: 10328589 Review.
-
Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.Neuro Oncol. 1999 Apr;1(2):124-37. doi: 10.1093/neuonc/1.2.124. Neuro Oncol. 1999. PMID: 11550308 Free PMC article. Review.
Cited by
-
Identification of prognostic biomarkers for glioblastomas using protein expression profiling.Int J Oncol. 2012 Apr;40(4):1122-32. doi: 10.3892/ijo.2011.1302. Epub 2011 Dec 15. Int J Oncol. 2012. PMID: 22179774 Free PMC article.
-
Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma.Proc Natl Acad Sci U S A. 2010 May 4;107(18):8357-62. doi: 10.1073/pnas.1000374107. Epub 2010 Apr 19. Proc Natl Acad Sci U S A. 2010. PMID: 20404171 Free PMC article.
-
Intratumoral patterns of clonal evolution in gliomas.Neurogenetics. 2010 May;11(2):227-39. doi: 10.1007/s10048-009-0217-x. Epub 2009 Sep 17. Neurogenetics. 2010. PMID: 19760258
-
Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology.Brain Pathol. 2002 Jan;12(1):67-86. doi: 10.1111/j.1750-3639.2002.tb00424.x. Brain Pathol. 2002. PMID: 11770903 Free PMC article. Review.
-
Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma.Clin Cancer Res. 2011 Nov 1;17(21):6693-701. doi: 10.1158/1078-0432.CCR-10-2774. Epub 2011 Sep 9. Clin Cancer Res. 2011. PMID: 21908579 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous